All In MedTech

FDA Clearance Tracker · P100046-S013

AtriCure Synergy Ablation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 15, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 15, 2022

Approved

Time to decision

259 days

Received Mar 1, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100046-S013
Device name
AtriCure Synergy Ablation System
Applicant location
Mason, OH
Received
Mar 1, 2022
Decided
Nov 15, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100046

Device type

Device class
Class III

Every decision under product code OCM

FDA's approval statement

As written in FDA's record.

Approval for the AtriCure Multifunctional Ablation Generator (MAG) as part of the Synergy Ablation System for use with the Isolator® Synergy Clamp™ (OLL2 and OSL2).

Source documents

Other decisions for AtriCure, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.